Cytomegalovirus persistence and T-cell immunosenescence in people aged fifty and older: A systematic review

Experimental Gerontology

Volumn 77, Issue , 2016, Pages 87-95

  Weltevrede, Marlies ^a   Eilers, Renske ^a,b   de Melker, Hester E ^a   van Baarle, Debbie ^a  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Cytomegalovirus; Immunosenescence; Memory T cells; T cell subsets; TEMRA

Indexed keywords

CD45RA ANTIGEN;

AGE DISTRIBUTION; AGING; ANTIGEN EXPRESSION; BLOOD LEVEL; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DATA ANALYSIS; DISEASE ASSOCIATION; HUMAN; IMMUNE RESPONSE; IMMUNOSENESCENCE; MEMORY T LYMPHOCYTE; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW; AGED; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; MIDDLE AGED; PHYSIOLOGY; T LYMPHOCYTE;

AGED; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; HUMANS; IMMUNOLOGIC MEMORY; IMMUNOSENESCENCE; MIDDLE AGED; T-LYMPHOCYTES;

EID: 84960375723     PISSN: 05315565     EISSN: 18736815     Source Type: Journal    
DOI: 10.1016/j.exger.2016.02.005     Document Type: Review

References (73)

1. Almanzar G., Schwaiger S., Jenewein B., Keller M., Herndler-Brandstetter D., Wurzner R., et al. Long-term cytomegalovirus infection leads to significant changes in the composition of the CD8+ T-cell repertoire, which may be the basis for an imbalance in the cytokine production profile in elderly persons. J. Virol. 2005, 79(6):3675-3683.
2. Alonso Arias R., Moro-Garcia M.A., Echeverria A., Solano-Jaurrieta J.J., Suarez-Garcia F.M., Lopez-Larrea C. Intensity of the humoral response to cytomegalovirus is associated with the phenotypic and functional status of the immune system. J. Virol. 2013, 87(8):4486-4495.
3. Benedetto D., Rao C.M., Cefalu C., Aguglia D.O., Cattadori G., D'Ascola D.G., et al. Effects of blood transfusion on exercise capacity in thalassemia major patients. PLoS ONE 2015, 10(5).
4. Boraschi D., Del Giudice G., Dutel C., Ivanoff B., Rappuoli R., Grubeck-Loebenstein B. Ageing and immunity: addressing immune senescence to ensure healthy ageing. Vaccine 2010, 28(21):3627-3631.
5. Borthwick N.J., Lowdell M., Salmon M., Akbar A.N. Loss of CD28 expression on CD8(+) T cells is induced by IL-2 receptor gamma chain signalling cytokines and type I IFN, and increases susceptibility to activation-induced apoptosis. Int. Immunol. 2000, 12(7):1005-1013.
6. Cannon M.J. Congenital cytomegalovirus (CMV) epidemiology and awareness. J. Clin. Virol. 2009, 46(Suppl. 4):S6-10.
7. Cannon M.J., Schmid D.S., Hyde T.B. Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection. Rev. Med. Virol. 2010, 20(4):202-213.
8. Centre for Reviews and Dissemination Systematic Reviews: CRD's Guidance for Undertaking Systematic Reviews in Health Care 2009, CRD University of York, York, ([cited 2014 February 17]. Available from: https://www.york.ac.uk/inst/crd/index_guidance.htm).
9. Chidrawar S., Khan N., Wei W., McLarnon A., Smith N., Nayak L., et al. Cytomegalovirus-seropositivity has a profound influence on the magnitude of major lymphoid subsets within healthy individuals. Clin. Exp. Immunol. 2009, 155(3):423-432.
10. Cicin-Sain L., Smyk-Pearson S., Currier N., Byrd L., Koudelka C., Robinson T., et al. Loss of naive T cells and repertoire constriction predict poor response to vaccination in old primates. J. Immunol. 2010, 184(12):6739-6745.
11. Cytomegalovirus (CMV) and congenital CMV infection [Internet] Atlanta: Centers for Disease Control and Prevention 2010, [updated 2010 July 28; cited 2014 6 August]. Available from: http://www.cdc.gov.cmv/transmission.html.
12. Derhovanessian E., Larbi A., Pawelec G. Biomarkers of human immunosenescence: impact of Cytomegalovirus infection. Curr. Opin. Immunol. 2009, 21(4):440-445.
13. Derhovanessian E., Theeten H., Hahnel K., Van Damme P., Cools N., Pawelec G. Cytomegalovirus-associated accumulation of late-differentiated CD4 T-cells correlates with poor humoral response to influenza vaccination. Vaccine 2013, 31(4):685-690.
14. Derhovanessian E., Maier A.B., Hahnel K., Zelba H., de Craen A.J., Roelofs H., et al. Lower proportion of naive peripheral CD8+ T cells and an unopposed pro-inflammatory response to human Cytomegalovirus proteins in vitro are associated with longer survival in very elderly people. Age (Dordr) 2013, 35(4):1387-1399.
15. Downs S., Black N. The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J. Epidemiol. Community Health 1998, 52(6):377-384.
16. ERBO-Platform Formulier III voor het beoordelen van een cohortonderzoek 2014, (cited 2014 February 17). Available from: http://dcc.cochrane.org/sites/dcc.cochrane.org/files/uploads/cohort.pdf.
17. ERBO-Platform Formulier IV voor het beoordelen van patiënt-controleonderzoek 2014, (cited 2014 February 17). Available from: http://dcc.cochrane.org/sites/dcc.cochrane.org/files/uploads/patient-controleonderzoek.pdf).
18. Fletcher J.M., Vukmanovic-Stejic M., Dunne P.J., Birch K.E., Cook J.E., Jackson S.E., et al. Cytomegalovirus-specific CD4+ T cells in healthy carriers are continuously driven to replicative exhaustion. J. Immunol. 2005, 175(12):8218-8225.
19. Fulop T., Larbi A., Pawelec G. Human T cell aging and the impact of persistent viral infections. Front. Immunol. 2013, 4:271.
20. Goronzy J.J., Weyand C.M. Understanding immunosenescence to improve responses to vaccines. Nat. Immunol. 2013, 14(5):428-436.
21. Goronzy J.J., Fulbright J.W., Crowson C.S., Poland G.A., O'Fallon W.M., Weyand C.M. Value of immunological markers in predicting responsiveness to influenza vaccination in elderly individuals. J. Virol. 2001, 75(24):12182-12187.
22. Hadrup S.R., Strindhall J., Kollgaard T., Seremet T., Johansson B., Pawelec G., et al. Longitudinal studies of clonally expanded CD8 T cells reveal a repertoire shrinkage predicting mortality and an increased number of dysfunctional cytomegalovirus-specific T cells in the very elderly. J. Immunol. 2006, 176(4):2645-2653.
23. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. The Cochrane Collaboration 2011, (updated March 2011). J. Higgins, S. Green (Eds.).
24. Karrer U., Mekker A., Wanke K., Tchang V., Haeberli L. Cytomegalovirus and immune senescence: culprit or innocent bystander?. Exp. Gerontol. 2009, 44(11):689-694.
25. Khan N., Hislop A., Gudgeon N., Cobbold M., Khanna R., Nayak L., et al. Herpesvirus-specific CD8 T cell immunity in old age: cytomegalovirus impairs the response to a coresident EBV infection. J. Immunol. 2004, 173(12):7481-7489.
26. Koch S., Larbi A., Ozcelik D., Solana R., Gouttefangeas C., Attig S., et al. Cytomegalovirus infection: a driving force in human T cell immunosenescence. Ann. N. Y. Acad. Sci. 2007, 1114:23-35.
27. Korndewal M.J., Mollema L., Tcherniaeva I., van der Klis F., Kroes A.C., Oudesluys-Murphy A.M., et al. Cytomegalovirus infection in the Netherlands: seroprevalence, risk factors, and implications. J. Clin. Virol. 2015, 63:53-58.
28. Kuparinen T., Marttila S., Jylhava J., Tserel L., Peterson P., Jylha M., et al. Cytomegalovirus (CMV)-dependent and -independent changes in the aging of the human immune system: a transcriptomic analysis. Exp. Gerontol. 2013, 48(3):305-312.
29. Lee W.W., Shin M.S., Kang Y., Lee N., Jeon S., Kang I. The relationship of cytomegalovirus (CMV) infection with circulatory IFN-alpha levels and IL-7 receptor alpha expression on CD8+ T cells in human aging. Cytokine 2012, 58(3):332-335.
30. Leung A.K., Sauve R.S., Davies H.D. Congenital cytomegalovirus infection. J. Natl. Med. Assoc. 2003, 95(3):213-218.
31. Libri V., Azevedo R.I., Jackson S.E., Di Mitri D., Lachmann R., Fuhrmann S., et al. Cytomegalovirus infection induces the accumulation of short-lived, multifunctional CD4 + CD45RA + CD27+ T cells: the potential involvement of interleukin-7 in this process. Immunology 2011, 132(3):326-339.
32. Lilleri D., Fornara C., Revello M.G., Gerna G. Human cytomegalovirus-specific memory CD8+ and CD4+ T cell differentiation after primary infection. Asian J. Infect. Dis. 2008, 198(4):536-543.
33. Litjens N.H., de Wit E.A., Betjes M.G. Differential effects of age, cytomegalovirus-seropositivity and end-stage renal disease (ESRD) on circulating T lymphocyte subsets. Immun. Ageing: I & A. 2011, 8(1):2.
34. Mahnke Y.D., Brodie T.M., Sallusto F., Roederer M., Lugli E. The who's who of T-cell differentiation: human memory T-cell subsets. Eur. J. Immunol. 2013, 43(11):2797-2809.
35. Manicklal S., Emery V.C., Lazzarotto T., Boppana S.B., Gupta R.K. The "silent" global burden of congenital cytomegalovirus. Clin. Microbiol. Rev. 2013, 26(1):86-102.
36. McElhaney J.E., Effros R.B. Immunosenescence: what does it mean to health outcomes in older adults?. Curr. Opin. Immunol. 2009, 21(4):418-424.
37. Mekker A., Tchang V.S., Haeberli L., Oxenius A., Trkola A., Karrer U. Immune senescence: relative contributions of age and cytomegalovirus infection. PLoS Pathog. 2012, 8(8).
38. Mendelson M., Monard S., Sissons P., Sinclair J. Detection of endogenous human cytomegalovirus in CD34+ bone marrow progenitors. J. Gen. Virol. 1996, 77(Pt 12):3099-3102.
39. Miller R.A. The aging immune system: primer and prospectus. Science 1996, 273(5271):70-74.
40. Moss P. The emerging role of cytomegalovirus in driving immune senescence: a novel therapeutic opportunity for improving health in the elderly. Curr. Opin. Immunol. 2010, 22(4):529-534.
41. Nikolich-Zugich J. Ageing and life-long maintenance of T-cell subsets in the face of latent persistent infections. Nat. Rev. Immunol. 2008, 8(7):512-522.
42. Northfield J., Lucas M., Jones H., Young N.T., Klenerman P. Does memory improve with age? CD85j (ILT-2/LIR-1) expression on CD8 T cells correlates with 'memory inflation' in human cytomegalovirus infection. Immunol. Cell Biol. 2005, 83(2):182-188.
43. Olsson J., Wikby A., Johansson B., Lofgren S., Nilsson B.O., Ferguson F.G. Age-related change in peripheral blood T-lymphocyte subpopulations and cytomegalovirus infection in the very old: the Swedish longitudinal OCTO immune study. Mech. Ageing Dev. 2000, 121(1-3):187-201.
44. Ouyang Q., Wagner W.M., Voehringer D., Wikby A., Klatt T., Walter S., et al. Age-associated accumulation of CMV-specific CD8+ T cells expressing the inhibitory killer cell lectin-like receptor G1 (KLRG1). Exp. Gerontol. 2003, 38(8):911-920.
45. Pawelec G. Hallmarks of human "immunosenescence": adaptation or dysregulation?. Immun. Ageing: I & A. 2012, 9(1):15.
46. Pawelec G., Derhovanessian E. Role of CMV in immune senescence. Virus Res. 2011, 157(2):175-179.
47. Pawelec G., Koch S., Franceschi C., Wikby A. Human immunosenescence: does it have an infectious component?. Ann. N. Y. Acad. Sci. 2006, 1067:56-65.
48. Pawelec G., Derhovanessian E., Larbi A., Strindhall J., Wikby A. Cytomegalovirus and human immunosenescence. Rev. Med. Virol. 2009, 19(1):47-56.
49. Pawelec G., Akbar A., Beverley P., Caruso C., Derhovanessian E., Fulop T., et al. Immunosenescence and cytomegalovirus: where do we stand after a decade?. Immun. Ageing: I & A. 2010, 7:13.
50. Pourgheysari B., Khan N., Best D., Bruton R., Nayak L., Moss P.A. The cytomegalovirus-specific CD4+ T-cell response expands with age and markedly alters the CD4+ T-cell repertoire. J. Virol. 2007, 81(14):7759-7765.
51. Reeves M., Sinclair J. Aspects of human cytomegalovirus latency and reactivation. Curr. Top. Microbiol. Immunol. 2008, 325:297-313.
52. Sallusto F., Lenig D., Forster R., Lipp M., Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 1999, 401(6754):708-712.
53. Sallusto F., Geginat J., Lanzavecchia A. Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu. Rev. Immunol. 2004, 22:745-763.
54. Saurwein-Teissl M., Lung T.L., Marx F., Gschosser C., Asch E., Blasko I., et al. Lack of antibody production following immunization in old age: association with CD8(+)CD28(-) T cell clonal expansions and an imbalance in the production of Th1 and Th2 cytokines. J. Immunol. 2002, 168(11):5893-5899.
55. Seckert C.K., Griessl M., Buttner J.K., Scheller S., Simon C.O., Kropp K.A., et al. Viral latency drives 'memory inflation': a unifying hypothesis linking two hallmarks of cytomegalovirus infection. Med. Microbiol. Immunol. 2012, 201(4):551-566.
56. Sindre H., Tjoonnfjord G.E., Rollag H., Ranneberg-Nilsen T., Veiby O.P., Beck S., et al. Human cytomegalovirus suppression of and latency in early hematopoietic progenitor cells. Blood 1996, 88(12):4526-4533.
57. Stagno S., Dworsky M.E., Torres J., Mesa T., Hirsh T. Prevalence and importance of congenital cytomegalovirus infection in three different populations. J. Pediatr. 1982, 101(6):897-900.
58. Stowe R.P., Kozlova E.V., Yetman D.L., Walling D.M., Goodwin J.S., Glaser R. Chronic herpesvirus reactivation occurs in aging. Exp. Gerontol. 2007, 42(6):563-570.
59. Stowe R.P., Peek M.K., Cutchin M.P., Goodwin J.S. Reactivation of herpes simplex virus type 1 is associated with cytomegalovirus and age. J. Med. Virol. 2012, 84(11):1797-1802.
60. Strelkauskas A., Strelkauskas J., Moszyk-Strelkauskas D. Microbiology. A Clinical Approach. 1 ed 2010, Garland Science, Taylor & Francis Group, New York.
61. Strindhall J., Skog M., Ernerudh J., Bengner M., Lofgren S., Matussek A., et al. The inverted CD4/CD8 ratio and associated parameters in 66-year-old individuals: the Swedish HEXA immune study. Age (Dordr) 2013, 35(3):985-991.
62. Sylwester A.W., Mitchell B.L., Edgar J.B., Taormina C., Pelte C., Ruchti F., et al. Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects. J. Exp. Med. 2005, 202(5):673-685.
63. Trzonkowski P., Mysliwska J., Szmit E., Wieckiewicz J., Lukaszuk K., Brydak L.B., et al. Association between cytomegalovirus infection, enhanced proinflammatory response and low level of anti-hemagglutinins during the anti-influenza vaccination-an impact of immunosenescence. Vaccine 2003, 21(25-26):3826-3836.
64. Vescovini R., Biasini C., Telera A.R., Basaglia M., Stella A., Magalini F., et al. Intense antiextracellular adaptive immune response to human cytomegalovirus in very old subjects with impaired health and cognitive and functional status. J. Immunol. 2010, 184(6):3242-3249.
65. Waller E.C., Day E., Sissons J.G., Wills M.R. Dynamics of T cell memory in human cytomegalovirus infection. Med. Microbiol. Immunol. 2008, 197(2):83-96.
66. Weinberger B., Lazuardi L., Weiskirchner I., Keller M., Neuner C., Fischer K.H., et al. Healthy aging and latent infection with CMV lead to distinct changes in CD8+ and CD4+ T-cell subsets in the elderly. Hum. Immunol. 2007, 68(2):86-90.
67. Wells G., Shea B., O'Connell D., Peterson J., Welch V., Losos M., et al. The Newcastle-Ottawa Scale (NOS) for Assessing The Quality of Nonrandomized Studies in Meta-analyses 2009, Ottawa, Ottawa Hospital Research Institute.
68. Weng N.P. Aging of the immune system: how much can the adaptive immune system adapt?. Immunity 2006, 24(5):495-499.
69. Wertheimer A.M., Bennett M.S., Park B., Uhrlaub J.L., Martinez C., Pulko V., et al. Aging and cytomegalovirus infection differentially and jointly affect distinct circulating T cell subsets in humans. J. Immunol. 2014, 192(5):2143-2155.
70. Wikby A., Ferguson F., Forsey R., Thompson J., Strindhall J., Lofgren S., et al. An immune risk phenotype, cognitive impairment, and survival in very late life: impact of allostatic load in Swedish octogenarian and nonagenarian humans. J. Gerontol. A Biol. Sci. Med. Sci. 2005, 60(5):556-565.
71. Wills M.R., Okecha G., Weekes M.P., Gandhi M.K., Sissons P.J., Carmichael A.J. Identification of naive or antigen-experienced human CD8(+) T cells by expression of costimulation and chemokine receptors: analysis of the human cytomegalovirus-specific CD8(+) T cell response. J. Immunol. 2002, 168(11):5455-5464.
72. Xie D., McElhaney J.E. Lower GrB+ CD62L high CD8 TCM effector lymphocyte response to influenza virus in older adults is associated with increased CD28null CD8 T lymphocytes. Mech. Ageing Dev. 2007, 128(5-6):392-400.
73. Zheng B., Han S., Takahashi Y., Kelsoe G. Immunosenescence and germinal center reaction. Immunol. Rev. 1997, 160:63-77.